Dose thresholds and local anhidrotic effect of botulinum A toxin injections (Dysport®) [15]

British Journal of Dermatology

Volumn 145, Issue 2, 2001, Pages 368-

  Moraru, E ^a   Voller, B ^a   Auff, E ^a   Schnider, P ^a  

^a University Clinic Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIPERSPIRANT AGENT; BOTULINUM TOXIN A; DILUENT; IODINE; SODIUM CHLORIDE; STARCH;

ANHIDROSIS; AXILLA; CLINICAL TRIAL; DILUTION; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUTION; DRUG STABILITY; HAND PALM; HUMAN; HYPERHIDROSIS; INJECTION SITE; LETTER; LOWER LEG; MAXIMUM ALLOWABLE CONCENTRATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SKIN; STAINING; SWEATING;

BIOLOGICAL AVAILABILITY; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERHIDROSIS;

EID: 0034797213     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04366.x     Document Type: Letter

References (9)

1. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections measured by sudometry
2. Botulinum toxin - A possible new treatment for axillary hyperhidrosis
3. Botulinum A toxin injection in focal hyperhidrosis
4. Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience
5. Treatment of focal hyperhidrosis with botulinum toxin type A. A long-term follow-up in 61 patients
6. Therapeutic botulinum type A toxin: Factors affecting potency
7. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis
8. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study
9. Botulinum A toxin: Dysport improvement of biological availability